Top Markets
#1 Palladium Network Palladium Network +27.92%
#2 Siren Siren +24.12%
#3 BankrCoin BankrCoin +21.06%
#4 Ankr Network Ankr Network +20.93%
#5 MarsCoin MarsCoin +20.74%
#6 Hive Hive +18.47%
#7 StonkBroker StonkBroker +14.51%
#8 Status Status +12.70%
#9 Prom Prom +11.13%
#10 Provenance Blockchain Provenance Blockchain +8.75%
Coin of the day
Palladium Network Palladium Network
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Satellos Bioscience Inc. Satellos Bioscience Inc.

Satellos Bioscience Inc.

MSCL
Kedudukan dalam Saham #18093
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Harga Saham
$10.22
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$212.97M
Perubahan (1 hari)
4.58%
Perubahan (1 tahun)
78.08%
Negara
CA
Perdagangan Satellos Bioscience Inc. (MSCL)

Kategori

Healthcare
Sejarah hasil dividen untuk Satellos Bioscience Inc. (MSCL)
Hasil dividen (TTM) bagi Satellos Bioscience Inc. (simbol saham: MSCL) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Satellos Bioscience Inc. (MSCL) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.48%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH